Long - term oral administration of branched chain amino acids after
curative resection of hepatocellular carcinoma: a prospective randomized trial.
While open surgery has been the mainstay of treatment for many of these tumors and often offers
curative resection, it is not without risks.
In this study, to our knowledge the largest randomized clinical trial of robotic - assisted laparoscopic surgery for patients with rectal adenocarcinoma suitable for
curative resection, there were no statistically significant differences in the rates of conversion to open laparotomy for robotic - assisted laparoscopic surgery compared with conventional laparoscopic surgery (8.1 % vs 12.2 %, respectively), and there were no statistically significant differences in CRM +, complication rates, or quality of life at 6 months.
Not exact matches
This study is designed to evaluate the safety and efficacy of neoadjuvant and adjuvant atezolizumab in participants with Stage IB, II or IIIA NSCLC who are eligible for surgical
resection with
curative intent.
The only
curative treatment for pancreatic cancer is complete surgical
resection.